280 related articles for article (PubMed ID: 6147827)
21. Antagonism of hypothermia and behavioral response to apomorphine: a simple, rapid and discriminating test for screening antidepressants and neuroleptics.
Puech AJ; Chermat R; Poncelet M; Doaré L; Simon P
Psychopharmacology (Berl); 1981; 75(1):84-91. PubMed ID: 6117921
[TBL] [Abstract][Full Text] [Related]
22. An organic selenium compound attenuates apomorphine-induced stereotypy in mice.
Machado MS; Rosa RM; Dantas AS; Reolon GK; Appelt HR; Braga AL; Henriques JA; Roesler R
Neurosci Lett; 2006 Dec; 410(3):198-202. PubMed ID: 17052842
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and properties of 4-substituted-1-piperazinyl-propyl derivatives of 1-phenyl-7-methylpyrimido-[4,5-d]pyrimidin-4-one.
Malinka W; Zajac HE; Dereń A; Zawisza T; Wilimowski M; Kedzierska-Goździk L; Barczyńska J; Rutkowska M; Wojewódzki W; Szelag A
Pol J Pharmacol Pharm; 1991; 43(5):369-79. PubMed ID: 1688093
[TBL] [Abstract][Full Text] [Related]
24. [The significance of evaluating animal behavior with psychotropic drugs and especially with antidepressive agents].
Puech A
Encephale; 1994 Jun; 20 Spec No 2():247-9. PubMed ID: 7916286
[No Abstract] [Full Text] [Related]
25. The effects of acrylamide on the behavioral suppression produced by psychoactive agents.
Tilson HA; Squibb RE
Neurotoxicology; 1982 Jul; 3(1):113-20. PubMed ID: 6890182
[TBL] [Abstract][Full Text] [Related]
26. [Neuroleptic-tricyclic antidepressant combination. Pharmacological aspects and therapeutic interest (author's transl)].
Boulenger JP; Zarifian E
Encephale; 1981; 7(1):5-28. PubMed ID: 6112132
[TBL] [Abstract][Full Text] [Related]
27. Behavioral pharmacology of the benzamides as compared to standard neuroleptics.
Worms P
Adv Biochem Psychopharmacol; 1982; 35():7-16. PubMed ID: 6128876
[No Abstract] [Full Text] [Related]
28. Pharmacological investigations on etoperidone, a new psychotropic agent.
Lisciani R; Baldini A; de Feo G; Silvestrini B
Arzneimittelforschung; 1978; 28(3):417-23. PubMed ID: 580751
[No Abstract] [Full Text] [Related]
29. [Effect of psychotropic preparations on the properties of tubulin in the brain].
Burbaeva GSh; Androsova LV; Klintsova AIu
Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(5):119-23. PubMed ID: 2901178
[TBL] [Abstract][Full Text] [Related]
30. [Psychotropic activity of thiaisochromane derivatives].
Val'dman AV; Shmidt Iu; Kozlovskaia MM; Andreas K; Fisher Kh
Farmakol Toksikol; 1981; 44(3):270-5. PubMed ID: 7286183
[TBL] [Abstract][Full Text] [Related]
31. Guidelines for the use of psychopharmaca in geriatric cases.
Simkó A
Ther Hung; 1989; 37(4):187-98. PubMed ID: 2576574
[TBL] [Abstract][Full Text] [Related]
32. [The characteristics of the effect of different classes of pharmacological substances on forced swimming in rats].
Molodavkin GM; Voronina TA; Mdzinarishvili AL
Eksp Klin Farmakol; 1994; 57(1):3-5. PubMed ID: 7908241
[TBL] [Abstract][Full Text] [Related]
33. Antidepressant effects assessed using behavior maintained under a differential-reinforcement-of-low-rate (DRL) operant schedule.
O'Donnell JM; Marek GJ; Seiden LS
Neurosci Biobehav Rev; 2005; 29(4-5):785-98. PubMed ID: 15893376
[TBL] [Abstract][Full Text] [Related]
34. Studies on the participation of the dopaminergic system in the central effects of chronically administered antidepressant drugs.
Kozyrska C; Zebrowska-Lupina I
Pol J Pharmacol Pharm; 1983; 35(2):115-26. PubMed ID: 6684769
[TBL] [Abstract][Full Text] [Related]
35. [The pharmacokinetic and immunopharmacological aspects of prodigiozan interaction with psychotropic agents].
Sibiriak SV; Alekhin EK
Farmakol Toksikol; 1990; 53(6):36-9. PubMed ID: 1981989
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological evaluation of 2-(4-methylaminobutoxy)diphenylmethane hydrochloride (MCI-2016), a new psychotropic drug with antidepressant activity.
Tobe A; Yoshida Y; Ikoma H; Tonomura S; Kikumoto R
Arzneimittelforschung; 1981; 31(8):1278-85. PubMed ID: 7197535
[TBL] [Abstract][Full Text] [Related]
37. Differences between antipsychotic drugs in persistence of brain levels and behavioral effects.
Cohen BM; Tsuneizumi T; Baldessarini RJ; Campbell A; Babb SM
Psychopharmacology (Berl); 1992; 108(3):338-44. PubMed ID: 1355924
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological profile of venlafaxine, a new antidepressant, given acutely.
Rogóz Z; Dziedzicka-Wasylewska M; Maj J
Pol J Pharmacol; 1998; 50(2):107-15. PubMed ID: 9798262
[TBL] [Abstract][Full Text] [Related]
39. Interactions between promazine and antidepressants at the level of cellular distribution.
Daniel WA; Wójcikowski J
Pharmacol Toxicol; 1997 Dec; 81(6):259-64. PubMed ID: 9444666
[TBL] [Abstract][Full Text] [Related]
40. 7-[3-(1-piperidinyl)propoxy]chromenones as potential atypical antipsychotics.
Bolós J; Gubert S; Anglada L; Planas JM; Burgarolas C; Castelló JM; Sacristán A; Ortiz JA
J Med Chem; 1996 Jul; 39(15):2962-70. PubMed ID: 8709130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
